EQL Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NGM:EQL Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
24 May 24	BuySEK 2,536,136	Axel Schorling	Individual	53,903	SEK 47.05
24 May 24	BuySEK 2,536,136	Axel Schorling	Individual	53,903	SEK 47.05
12 Dec 23	SellSEK 9,900,002	FÅRö Capital Ab	Company	300,000	SEK 33.00

Insider Buying: EQL insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 19 shareholders own 74.3% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
30%	Cadila Pharmaceuticals Limited	8,718,500	SEK 538.8m	0%	no data
28%	FÅRö Capital Ab	8,127,348	SEK 502.3m	0%	97.42%
3.29%	Avanza Fonder AB	956,193	SEK 59.1m	0%	0.13%
2.19%	SEB Investment Management AB	636,493	SEK 39.3m	0%	0.01%
1.54%	Sten Irwe	447,580	SEK 27.7m	0%	no data
1.24%	Lars Fåhraeus	360,389	SEK 22.3m	0%	no data
1.19%	Carnegie Fonder AB	345,857	SEK 21.4m	0%	0.04%
1.1%	Emanuel Eriksson	319,700	SEK 19.8m	0%	no data
1.07%	Axel Schorling	311,016	SEK 19.2m	21%	no data
1.06%	Cliens Kapitalförvaltning AB	308,074	SEK 19.0m	0%	0.06%
1.03%	Martin Søkjer-Petersen	299,355	SEK 18.5m	0%	no data
0.88%	Alexander Brising	256,543	SEK 15.9m	0%	no data
0.86%	Schroder Investment Management Limited	250,000	SEK 15.4m	0%	no data
0.71%	Amundi Asset Management SAS	205,937	SEK 12.7m	302%	no data
0.052%	Martin Kristofferson	15,200	SEK 939.4k	0%	no data
0.047%	Anna Jonsson	13,729	SEK 848.5k	0%	no data
0.034%	Per Svangren	10,000	SEK 618.0k	0%	no data
0.034%	Anders Mansson	10,000	SEK 618.0k	0%	no data
0.0086%	Linda Neckmar	2,500	SEK 154.5k	0%	no data